Other
Jul 2023Kilobaser filed for insolvency after a failed financing round and weak U.S. expansion; the article reported 19 employees and about 30 creditors.
SourceDesktop DNA Printer. The Nespresso Machine for DNA.
Company research
Public company, workplace, funding, and market signals
Overview
Kilobaser is an Austrian life-science hardware company that makes plug-and-play benchtop DNA/RNA synthesizers and related consumables so labs can produce custom oligos, probes, and modified nucleic acids on demand. Public sources also show a 2023 insolvency event followed by a 2024 asset-sale restart and continued operations from Graz.
Primary product
Kilobaser One-XT benchtop DNA/RNA synthesizer
Founded
2014
Headquarters
Graz, Austria
Team size
1-10
Industry
Biotechnology Research
Sub-industry
DNA/RNA synthesis hardware
Offices
Graz, Austria
Business model
direct hardware sales
consumables and reagent cartridges
support and training services
installation services
sample oligo evaluation service
Funding
Stage
post-bankruptcy asset sale
Total raised
$125K
Latest round
Asset Sale · Jan 2024
People & investors
Leadership
Founder & CSO
Co-Founder & CTO
Head of Sales
After Sales Manager
International Communications Manager
Development Engineer
Work & culture
Biohacker-founded and product-driven, with public company values centered on independence, reliability, competence, support, curiosity, agility, and honesty. The company’s messaging emphasizes democratizing DNA/RNA synthesis and making in-house production simple for researchers.
Product & market
Pricing
Quote-based direct hardware sales with consumables; add-on installation, warranty, and sample/validation services.
Differentiators
- —plug-and-play benchtop form factor
- —microfluidic chip and cartridge architecture
- —about 50x lower reagent use than conventional desktop synthesis
- —on-demand in-house production of custom oligos and probes
- —offline operation without mandatory internet
- —portable N2Go nitrogen supply that removes external gas cylinders
Technology
microfluidic chip-based synthesis
cartridge-based reagent delivery
phosphoramidite chemistry
automated oligo synthesis
offline/local operation with USB updates
integrated nitrogen supply (N2Go)
Customers
Academic research labs
Biotechnology companies
MatMaCorp
Biogenes Technologies
Evolutta Agro Biotech
IST Austria
UnternehmerTUM
U.S. Department of War / FFBS program
Competitors
DNA Script
Evonetix
Molecular Assemblies
Twist Bioscience
outsourced oligo synthesis services
Scale & contact
Estimated revenue
under $1M (public estimate: ~$285K)
Estimated monthly visits
3.4K
Traffic estimate as of Oct 2025
Signals & risks
Acquisition
Jan 2024Biogenes Technologies financed a rescue of Kilobaser assets out of bankruptcy, leading to a new company structure (MABEAL GmbH) and continuation of the product line.
SourceLatest news
Kilobaser LinkedIn · Jul 2026
Kilobaser says it is part of the newly fielded FFBS program, positioning its synthesizer as a field tool for generating primers and custom assays quickly at the point of need.
U.S. Naval Research Laboratory · Jun 2026
Official NRL coverage of the FFBS / F-FAST transition explains how portable sequencing and on-demand assay generation support field operations; it explicitly mentions Kilobaser as the primer synthesizer used after sequencing.
Kilobaser website · May 2026
Kilobaser launched N2Go, a compact nitrogen generator meant to replace gas cylinders and support the One and One-XT platforms at the benchtop or in mobile deployments.
brutkasten · Jan 2024
The article reports that Biogenes Technologies helped finance a restart after insolvency and that the founders formed a new company to acquire the assets from bankruptcy.
TrendingTopics · Jul 2023
Coverage of the insolvency filing says the company’s financing round failed, U.S. expansion underperformed, and the business could not continue without new capital.
Jobs and careers at Kilobaser
0 jobs at Kilobaser
No open positions
Check back later for new openings